Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

作者: Carmine Pinto , Carlo Antonio Barone , Giampiero Girolomoni , Elvio Grazioso Russi , Marco Carlo Merlano

DOI: 10.1634/THEONCOLOGIST.2010-0298

关键词:

摘要: Background. Cetuximab was demonstrated by clinical trials to improve response rate and survival of patients with metastatic nonresectable colorectal cancer or carcinoma the head neck. Appropriate management skin toxicity associated epidermal growth factor receptor inhibitor (EGFR-i) therapy is necessary allow adequate drug administration quality life outcomes.

参考文章(64)
J. Baselga, D. Pfister, M.R. Cooper, R. Cohen, B. Burtness, M. Bos, G. D’Andrea, A. Seidman, L. Norton, K. Gunnett, J. Falcey, V. Anderson, H. Waksal, J. Mendelsohn, Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin Journal of Clinical Oncology. ,vol. 18, pp. 904- 914 ,(2000) , 10.1200/JCO.2000.18.4.904
Siegfried Segaert, Josep Tabernero, Olivier Chosidow, Thomas Dirschka, Joern Elsner, Luca Mancini, Tim Maughan, Jean-Franuois Morere, Armando Santoro, Alberto Sobrero, Eric Van Cutsem, Alison Layton, The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. Journal Der Deutschen Dermatologischen Gesellschaft. ,vol. 3, pp. 599- 606 ,(2005) , 10.1111/J.1610-0387.2005.05058.X
Suzanne S. S. Mak, Alexander Molassiotis, Wai-man Wan, Idy Y.M. Lee, Eunice S. J. Chan, The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing. Cancer Nursing. ,vol. 23, pp. 220- 229 ,(2000) , 10.1097/00002820-200006000-00010
Andreas Wollenberg, Nicolas Moosmann, Elisabeth Klein, Kerstin Katzer, A tool for scoring of acneiform skin eruptions induced by EGF receptor inhibition. Experimental Dermatology. ,vol. 17, pp. 790- 792 ,(2008) , 10.1111/J.1600-0625.2008.00715.X
Christian Giro, Bernhard Berger, Edwin Bölke, I. Frank Ciernik, Frederic Duprez, Laura Locati, Sophie Maillard, Mahmut Ozsahin, Raphael Pfeffer, A. Gerry Robertson, Johannes A. Langendijk, Wilfried Budach, High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes Radiotherapy and Oncology. ,vol. 90, pp. 166- 171 ,(2009) , 10.1016/J.RADONC.2008.09.007
Aminah Jatoi, Erin M. Green, Kendrith M. Rowland, Jr., Daniel J. Sargent, Steven R. Alberts, Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147 Oncology. ,vol. 77, pp. 120- 123 ,(2009) , 10.1159/000229751
Anna Liza C. Agero, Stephen W. Dusza, Cristiane Benvenuto-Andrade, Klaus J. Busam, Patricia Myskowski, Allan C. Halpern, Dermatologic side effects associated with the epidermal growth factor receptor inhibitors Journal of the American Academy of Dermatology. ,vol. 55, pp. 657- 670 ,(2006) , 10.1016/J.JAAD.2005.10.010
Roy S. Herbst, Patricia M. LoRusso, Michele Purdom, Deborah Ward, Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management Clinical Lung Cancer. ,vol. 4, pp. 366- 369 ,(2003) , 10.3816/CLC.2003.N.016
Patrizia Racca, Laura Fanchini, Virginia Caliendo, Giuliana Ritorto, Walter Evangelista, Roberta Volpatto, Enrica Milanesi, Angelica Ciorba, Myriam Paris, Ivan Facilissimo, Giuseppe Macripò, Mario Clerico, Libero Ciuffreda, Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation Clinical Colorectal Cancer. ,vol. 7, pp. 48- 54 ,(2008) , 10.3816/CCC.2008.N.007